⌘K
t
Craneware plc purchased 42,302 of its Ordinary Shares on 23 March 2026, through Peel Hunt LLP on the London Stock Exchange, as part of a buyback programme announced on 16 March 2026. The shares were bought at prices between 1,355.00 pence and 1,375.00 pence per share, with a weighted average price of 1,364.95 pence. Following this transaction, the Company will hold 287,830 Ordinary Shares in Treasury, leaving 35,254,339 Ordinary Shares in issue.
| Date | 25 Mar 2026 |
| Time | 07:00:06 |
| Category | Capital structure |
| ID | 9808X |
25 March 2026
Craneware plc
("Craneware", or the "Company")
Transaction in Own Shares
Craneware (AIM: CRW.L), a leader in healthcare financial performance solutions, announces it has purchased the following number of its Ordinary Shares of 1p each through Peel Hunt LLP on the London Stock Exchange.
|
Date of purchase |
23 March 2026 |
|
Number of ordinary shares purchased: |
42,302 |
|
Lowest price per share (pence): |
1,355.00 |
|
Highest price per share (pence): |
1,375.00 |
|
Weighted average price per day (pence): |
1,364.95 |
The Company will hold the purchased shares in Treasury. Following the purchase of these shares, the Company will have 35,254,339 Ordinary Shares in issue (excluding Treasury shares), and the Company will hold 287,830 Ordinary Shares in Treasury.
The figure of 35,254,339 represents the total voting rights in the Company and may be used by shareholders as the denominator for calculating whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The table below contains detailed information about the purchases made as part of the buyback programme which was announced by the Company on 16 March 2026 (the "Programme").
Aggregate information:
|
Venue |
Volume Weighted Average Price (p) |
Aggregated Volume |
Lowest price paid per share (p) |
Highest price paid per share (p) |
|
AIMX |
1,364.95 |
42,302 |
1,355.00 |
1,375.00 |
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by Peel Hunt on behalf of the Company as part of the Programme is detailed below:
|
Number of shares purchased |
Transaction price (pence) |
Venue |
Time of each trade |
Transaction Reference Number |
|
10,000 |
1,355.00 |
AIMX |
11:43:25 |
00191193258TRLO0 |
|
15,000 |
1,360.00 |
AIMX |
11:47:08 |
00191194062TRLO0 |
|
17,302 |
1,375.00 |
AIMX |
13:23:37 |
00191206745TRLO0 |
For further information please contact:
|
Craneware plc |
+44 (0)131 550 3100 |
|
Keith Neilson, CEO |
|
|
Craig Preston, CFO |
|
|
|
|
|
Alma Strategic Communications |
+44 (0)20 3405 0205 |
|
Caroline Forde, Kinvara Verdon, Louisa El-Ahwal |
craneware@almastrategic.com |
|
|
|
|
Peel Hunt (NOMAD and Joint Broker) |
+44 (0)20 7418 8900 |
|
Neil Patel, Benjamin Cryer, Kate Bannatyne |
|
About Craneware
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.
Learn more at www.thecranewaregroup.com